1.O'Grady, NP, Alexander, M, Dellinger, EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Morb Mortal Wkly Recomm Rep 2002;51(RR-10):1–29.
2.Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–1601.
3.Biwersi, C, Hepping, N, Bode, U, et al. Bloodstream infections in a German paediatric oncology unit: prolongation of inpatient treatment and additional costs. Int J Hyg Environ Health 2009; 212:541–546.
4.Siempos, II, Kopterides, P, Tsangaris, I, Dimopoulou, I, Armaganidis, AE. Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis. Crit Care Med 2009;37:2283–2289.
5.Elward, AM, Hollenbeak, CS, Warren, DK, Fraser, VJ. Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics 2005;115:868–872.
6.Edwards, JR, Peterson, KD, Mu, Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009;37: 783–805.
7.Adler, A, Yaniv, I, Steinberg, R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 2006;62:358–365.
8.Allen, RC, Holdsworth, MT, Johnson, CA, et al. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 2008;51:53–58.
9.Ross, MN, Haase, GM, Poole, MA, Burrington, JD, Odom, LF. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet 1988;167:141–144.
10.Smith, TL, Pullen, GT, Crouse, V, Rosenberg, J, Jarvis, WR. Bloodstream infections in pediatric oncology outpatients: a new healthcare systems challenge. Infect Control Hosp Epidemiol 2002; 23:239–243.
11.Berenholtz, SM, Pronovost, PJ, Lipsett, PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004;32:2014–2020.
12.Pronovost, P, Needham, D, Berenholtz, S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725–2732.
13.Costello, JM, Morrow, DF, Graham, DA, et al. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008; 121:915–923.
14.Miller, MR, Griswold, M, Harris, JM, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics 2010;125:206–213.
15.Jeffries, HE, Mason, W, Brewer, M, et al. Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative. Infect Control Hosp Epidemiol 2009;30:645–651.
16.Chelliah, A, Heydon, KH, Zaoutis, TE, et al. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Pediatr Infect Dis J 2007;26:816–820.
17.Garland, JS, Alex, CP, Mueller, CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107:1431–1436.
18.Safdar, N, Maki, DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 2006;43:474–484.
19.Horan, TC, Andrus, M, Dudeck, MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309–332.
20.Ogden, CL, Kuczmarski, RJ, Flegal, KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45–60.
21.Lin, MY, Hota, B, Khan, YM, et al. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 2010;304:2035–2041.
22.Niedner, MF, 2008 National Association of Children's Hospitals and Related Institutions Pediatric Intensive Care Unit Patient Care Focus Group. The harder you look, the more you find: catheter-associated bloodstream infection surveillance variability. Am J Infect Control 2010;38:585–595.
23.Fuller, AK, Uglik, KM, Savage, WJ, Ness, PM, King, KE. Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single-donor platelets. Transfusion 2009;49: 2588–2593.
24.Kaplan, J, Sarnaik, S, Gidin, J, Lusher, J. Diminished helper/suppressor ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984;64:308–310.
25.Wood, ML, Gottschalk, R, Monaco, AP. Effect of blood transfusion on IL-2 production. Transplantation 1988;45:930–935.
26.Waymack, JP, Gallon, L, Barcelli, U, Alexander, JW. Effect of blood transfusions on macrophage function in a burned animal model. Curr Surg 1986;43:305–307.
27.Aslam, R, Speck, ER, Kim, M, Freedman, J, Semple, JW. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC class I molecules and is independent of white cells. Transfusion 2008;48:1778–1786.
28.Blumberg, N, Spinelli, SL, Francis, CW, Taubman, MB, Phipps, RP. The platelet as an immune cell: CD40 ligand and transfusion immunomodulation. Immunol Res 2009;45:251–260.
29.Blumberg, N, Heal, JM. Effects of transfusion on immune function: cancer recurrence and infection. Arch Pathol Lab Med 1994; 118:371–379.
30.Houbiers, JG, van de Velde, CJ, van de Watering, LM, et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997;37:126–134.
31.Bodey, GP, Buckley, M, Sathe, YS, Freireich, EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328–340.
32.Viscoli, C, Castagnola, E, Giacchino, M, et al. Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Eur J Cancer 1999;35:770–774.
33.Chathas, MK, Paton, JB, Fisher, DE. Percutaneous central venous catheterization: three years' experience in a neonatal intensive care unit. Am J Dis Child 1990;144:1246–1250.
34.Casado-Flores, J, Valdivielso-Serna, A, Perez-Jurado, J, et al. Subclavian vein catheterization in critically ill children: analysis of 322 cannulations. Intensive Care Med 1991;17:350–354.
35.Abbas, AA, Fryer, CJ, Paltiel, C, et al. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatr Blood Cancer 2004; 42:325–331.
36.Simon, A, Ammann, RA, Bode, U, et al. Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 2008;8:70.
37.Stamou, SC, Maltezou, HC, Pourtsidis, A, et al. Hickman-Broviac catheter-related infections in children with malignancies. Mt Sinai J Med 1999;66:320–326.
38.Garner, JS, Jarvis, WR, Emori, TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16: 128–140.
39.DiazGranados, CA, Zimmer, SM, Klein, M, Jernigan, JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005;41:327–333.
40.Butler, AM, Olsen, MA, Merz, LR, et al. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort. Infect Control Hosp Epidemiol 2010;31:28–35.